Original language | Undefined |
---|---|
Pages (from-to) | 2-2 |
Number of pages | 1 |
Journal | British Journal of Haematology |
Volume | 165 |
Issue number | 1 |
Publication status | Published - 2014 |
Mature response data from a phase 2 study of PI3K-delta inhibitor idelalisib in patients with double (rituximab and alkylating agent)-refractory indolent B-cell non-Hodgkin lymphoma (iNHL)
A. Davies, A. K. Gopal, B. S. Kahl, S. de Vos, N. D. Wagner-Johnston, S. J. Schuster, W. J. Jurczak, I. W. Flinn, C. R. Flowers, R. Dansey, P. Martin, A. Viardot, K. A. Blum, A. H. Goy, J. Gribben, H-T Arkenau, R. Johnson, K. Linton, P. L. Zinzani, M. Dreyling
Research output: Contribution to journal › Meeting Abstract › peer-review